1. Home
  2. AMG vs BIO Comparison

AMG vs BIO Comparison

Compare AMG & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Affiliated Managers Group Inc.

AMG

Affiliated Managers Group Inc.

HOLD

Current Price

$305.23

Market Cap

8.0B

Sector

Finance

ML Signal

HOLD

Logo Bio-Rad Laboratories Inc.

BIO

Bio-Rad Laboratories Inc.

HOLD

Current Price

$312.45

Market Cap

6.9B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
AMG
BIO
Founded
1993
1952
Country
United States
United States
Employees
5600
7450
Industry
Investment Managers
Biotechnology: Laboratory Analytical Instruments
Sector
Finance
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
8.0B
6.9B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
AMG
BIO
Price
$305.23
$312.45
Analyst Decision
Strong Buy
Buy
Analyst Count
4
4
Target Price
$384.00
$339.75
AVG Volume (30 Days)
265.6K
471.8K
Earning Date
05-01-2026
04-30-2026
Dividend Yield
0.01%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$11.98
$2.74
Revenue Next Year
$9.34
$3.20
P/E Ratio
$14.55
$9.72
Revenue Growth
N/A
N/A
52 Week Low
$172.54
$211.43
52 Week High
$334.78
$343.12

Technical Indicators

Market Signals
Indicator
AMG
BIO
Relative Strength Index (RSI) 56.25 68.29
Support Level $290.53 $293.88
Resistance Level $308.06 $330.54
Average True Range (ATR) 7.63 9.86
MACD 0.21 6.66
Stochastic Oscillator 64.57 90.63

Price Performance

Historical Comparison
AMG
BIO

About AMG Affiliated Managers Group Inc.

Affiliated Managers Group offers investment strategies to investors through its network of affiliates. The firm typically buys a majority interest in small to mid-size boutique asset managers, receiving a fixed percentage of revenue from these firms in return. Affiliates operate independently, with AMG providing strategic, operational, and technology support, as well as global distribution. At the end of December 2025, AMG's affiliate network—which includes firms like Abacus Capital and Pantheon dedicated to private markets (which accounted for 18% of AUM), AQR Capital and Capula Investment Management in liquid alternatives (28%), and Harding Loevner, Tweedy Browne, Parnassus, and Yacktman in equities, multi-asset, and bond strategies (54%)—had $813.3 billion in managed assets.

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

Share on Social Networks: